Government-private panel discusses post-FTA steps

Published: 2009-06-25 07:00:00

Updated: 2009-06-25 07:00:00

Korean pharmaceutical companies need to assess the damage that its free trade deals with other countries would cause in the local pharmaceutical industry in the future, a government official said.

In an information session on June 22, the health ministry official Ha Tae-gil said that domestic ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK